Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TactuPump Forte for Atrophic Acne Scars
NCT02735421Phase 4Completed
- Sponsor
- Galderma
- Start
- May 2016
- Primary completion
- Jun 2017
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, single-blind trial of adapalene + benzoyl peroxide in acne vulgaris and atrophic acne scars (2 arms), sponsored by Galderma. Primary endpoint: Total Atrophic Acne Scar Count Per Half-face at 24 weeks. Started May 2016; status: completed.
02
Drugs
adapalene + benzoyl peroxide
03
Conditions
acne vulgarisatrophic acne scars
Beyond the preview
Go deeper on NCT02735421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02735421.